← back to search

Vivek Naranbhai

Molecular Research Institute · US
Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Immune Cell Function and Interaction, and Tuberculosis Research and Epidemiology.
h-index
44
citations
9,626
works
171
NIH funding
primary concept
Medicine
email

Recent publications

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Nature Genetics 2023cited by 181position: middledoi
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
Science Translational Medicine 2023cited by 47position: middledoi
Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture
eLife 2023cited by 37position: middledoi
Prognostic biomarkers for survival in mucosal melanoma
Pigment Cell & Melanoma Research 2023cited by 7position: middledoi
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Cell 2022cited by 1,089position: middledoi
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Cell 2022cited by 260position: firstdoi
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy
JAMA Dermatology 2022cited by 128position: middledoi
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank
Nature Communications 2022cited by 106position: middledoi
Genome-wide association study of leprosy in Malawi and Mali
PLoS Pathogens 2022cited by 5position: middledoi
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Cell 2021cited by 1,538position: middledoi
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
Cell 2021cited by 91position: middledoi
HLA tapasin independence: broader peptide repertoire and HIV control
Proceedings of the National Academy of Sciences 2020cited by 84position: middledoi
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency
BMC Medicine 2020cited by 7position: middledoi
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
Nature Immunology 2019cited by 101position: middledoi
Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
JCI Insight 2019cited by 63position: middledoi
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cells
Science 2018cited by 152position: middledoi
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4
Nature Communications 2018cited by 35position: middledoi
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
Scientific Reports 2017cited by 33position: middledoi
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Nature Communications 2016cited by 271position: middledoi
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children
The American Journal of Human Genetics 2016cited by 47position: middledoi
Genital Inflammation and the Risk of HIV Acquisition in Women
Clinical Infectious Diseases 2015cited by 430position: middledoi
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
EBioMedicine 2015cited by 71position: firstdoi
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life
BMC Medicine 2014cited by 91position: firstdoi
A systematic review of definitions of extreme phenotypes of HIV control and progression
AIDS 2013cited by 108position: middledoi
IFITM3 and Susceptibility to Respiratory Viral Infections in the Community
The Journal of Infectious Diseases 2013cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adrian V. S. Hill · Centre for Human Genetics6 papers (2013–2023)A. John Iafrate · Harvard University5 papers (2021–2023)Wilfredo F. García-Beltrán · Ragon Institute of MGH, MIT and Harvard4 papers (2021–2022)Helen McShane · University of Oxford3 papers (2014–2017)Benjamin P. Fairfax · University of Oxford3 papers (2015–2022)James J. Gilchrist · Centre for Human Genetics3 papers (2018–2023)Evan C. Lam · Ragon Institute of MGH, MIT and Harvard3 papers (2021–2022)Mary Carrington · Cancer Institute (WIA)3 papers (2021–2022)Tom Parks · Imperial College London3 papers (2013–2023)Kerri St. Denis · Yale University3 papers (2021–2022)Helen A. Fletcher · London School of Hygiene & Tropical Medicine3 papers (2014–2017)Alejandro B. Balazs · Ragon Institute of MGH, MIT and Harvard3 papers (2021–2022)Rhoda Tano-Menka · Ragon Institute of MGH, MIT and Harvard2 papers (2021–2022)Fernando Senjobe · Ragon Institute of MGH, MIT and Harvard2 papers (2021–2022)Anna Rautanen · Centre for Human Genetics2 papers (2013–2018)Gaurav D. Gaiha · Harvard University2 papers (2021–2022)Matthew K. O’Shea · University of Birmingham2 papers (2015–2017)Bruce D. Walker · Active Technologies (Italy)2 papers (2021–2022)Onosereme Ofoman · Massachusetts General Hospital2 papers (2022–2022)Aaron G. Schmidt · Technische Universität Dresden2 papers (2021–2022)